IM Cannabis Closes $225,000 Convertible Note Financing In Private Placement
IM Cannabis Corp. (" IMC " or the " Company ") (NASDAQ: IMCC ), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the " Lender "). Pursuant to a note purchase agreement between the Company and Lender dated July 1, 2026 (the " July Note Purchase Agreement "), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the " July Note "). The Company intends to use the net proceeds from the July Note for general corporate purposes.
IM Cannabis Corp. (" IMC " or the " Company ") (NASDAQ: IMCC ), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the " Lender ").
Pursuant to a note purchase agreement between the Company and Lender dated July 1, 2026 (the " July Note Purchase Agreement "), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the " July Note ").
The Company intends to use the net proceeds from the July Note for general corporate purposes.